Approval · Notice of Compliance 23927 · 2020
FIBRYGA: Notice of Compliance 23927
Issued July 16, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23927
- Date
- July 16, 2020
- Company
- Octapharma Pharmazeutika Produktionsges M B HVienna, Vienne, Austria
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FIBRYGA | Not yet assigned | — |
Medicinal ingredients
- FIBRINOGEN (HUMAN) 1 G per VIAL